Pharmaceutical companies just raised list prices for over 500 medicines, including Novo Nordisk’s Ozempic, Gilead’s HIV-1 ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Jan 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab and the U.S. government have settled a billion-dollar patent ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

However, some of these medications have caused serious side effects that alter the lives of those taking them. In 2001, Gilead Sciences released the tenofovir disoproxil fumarate medication ...

Livdelzi will launch at a list price of $12,606 for a 30-day treatment ... Seigerman predicted peak sales of $847 million for Gilead's drug. Both the PPAR drugs compete with Intercept Pharma's ...